Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer

Cisplatin is a widely used platinum‐based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have small‐cell lung cancer who developed ischemic cerebrovascular accident...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashid, Farah, Omar, Nabil E., Aaekl, Hassan, Al Homsi, Ussama, Shablak, Alaaeldin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585048/
https://www.ncbi.nlm.nih.gov/pubmed/36285031
http://dx.doi.org/10.1002/ccr3.6469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585048/
https://www.ncbi.nlm.nih.gov/pubmed/36285031
http://dx.doi.org/10.1002/ccr3.6469

Ejemplares similares